SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001043135-02-000084
Filing Date
2002-06-10
Accepted
2002-06-10 14:42:38
Documents
1

Document Format Files

Seq Description Document Type Size
1 NEOPHARM INC neol13gamd1.txt SC 13G/A 17562
  Complete submission text file 0001043135-02-000084.txt   19617
Mailing Address C/O WILSON SONSIN GOODRICH & ROSETI 650 PAGE MILL ROAD PALO ALTO CA 94304
Business Address 150 FIELD DRIVE SUITE 195 LAKE FORREST IL 60045 8472958678
NEOPHARM INC (Subject) CIK: 0000942788 (see all company filings)

IRS No.: 510327886 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-49690 | Film No.: 02674844
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 114 WEST 47TH STREET SUITE 1926 NEW YORK NY 10036
Business Address 114 WEST 47TH ST STE 1926 NEW YORK NY 10036 2128193200
KERN CAPITAL MANAGEMENT LLC /ADV (Filed by) CIK: 0001043135 (see all company filings)

IRS No.: 133958232 | State of Incorp.: DE | Fiscal Year End: 1231